Membreve, Janejane .
HRN: 22-38-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
CEFUROXIME 1.5GM (VIAL)
01/11/2023
01/11/2023
IVT
1.5 Gms
Q8 X 3 Doses
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes